Revenue grew 9.4% to $320.2M in fiscal 2026, led by 18.4% Med Tech growth and margin expansion despite tariffs. Guidance for 2027 calls for 5%-6.5% revenue growth, 12%-15% Med Tech growth, and continued investment in clinical data and innovation.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.